Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q3 FY2025 Earnings Presentation
36 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Jan 27, 2025
Slide 1: Cover letter to stock exchanges for Q3FY25 results
January 27, 2025 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 54
Slide 2: Q3 & 9M FY25 Earnings Presentation
Q3 & 9M FY25 Earnings Presentation Jan 27, 2025
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t
Slide 4: Q3 & 9M FY25 Performance Highlights
Q3 & 9M FY25 Performance Highlights
Slide 5: 9M FY25 Performance Summary
9M FY25 Performance Summary Bed Capacity* Revenue EBITDA Rs. 6,487 mn Rs. 1,632 mn 2,300+ beds +32% YoY +22% YoY EBITDA Margin PAT PAT Margin 25.2% Rs. 918 mn 14.2% -192bps YoY +21% YoY -130bps YoY Occupancy ARPOB ALOS 61% Rs. 30,614 4.38 +7% YoY +8% YoY * 1,605 beds, excluding upcoming hospitals in
Slide 6: Q3 FY25 Performance Summary
Q3 FY25 Performance Summary Revenue EBITDA EBITDA Margin Rs. 2,192 mn Rs. 549 mn 25.1% +31% YoY +18% YoY -277bps YoY PAT PAT Margin Net Cash Rs. 305 mn 13.9% -377bps YoY Rs. 5,605 mn +3% YoY Occupancy ARPOB ALOS 60% Rs. 30,652 4.30 +8% YoY +4% YoY 5
Slide 7: Robust Improvement in Financial Parameters
Robust Improvement in Financial Parameters Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 80 0 30.0% 795 790 27.8% 785 780 775 29.0% 770 765 760 755 750 +31% YoY 745 28.0% 26.2% 740 735 730 725 25.3% 720 27.0% 715 25.1% 25.1% 710 705 700 69 5 26.0% 69 0 68 5 68 0 +1% QoQ 675 670 66 5 25.0% 66 0 65 5 65 0
Slide 8: Healthy performances across operational metrics
Healthy performances across operational metrics IPD & OPD Volumes (in ‘000s) Occupancy (%) 61% 60% IPD Volume OPD Volume 60% 116 57% 102 109 94 90 52% 99 92 82 78 87 12 12 15 17 17 Q3FY24 Q4FY24 Q1FY25 Q2FY25 Q3FY25 Q3FY24 Q4FY24 Q1FY25 Q2FY25 Q3FY25 IPD & OPD Revenue (Rs mn) ARPOB (Rs.) IPD Revenue
Slide 9: Diversifying revenues across hospitals
Diversifying revenues across hospitals Greater Noida, Greater Noida 35%, 30% Rs. 582 mn Faridabad, Rs. 663 mn Jhansi-Orchha, 5% 6%, Rs. 111 mn Rs. 94 mn Jhansi- Q3 FY24 Orchha Q3 FY25 Rs. 1,668 mn 9% Rs. 2,192 mn Rs. 182 mn Noida, Noida Noida, Extension 26%, Noida 20% 36% Rs. 434 mn Extension, Rs. 4
Slide 10: Expanding high value specialties across hospitals
Expanding high value specialties across hospitals Diverse mix of specialties at all hospitals Noida extension hospital registered highest share of super specialties Q3 17% 13% 11% 10% 10% 8% 7% 6% 5% 5% 5% FY2025 Pediatrics, 3% Others, 4% Oncology Pulmonology, 6% 21% Gynecology Q3 6% 26% 12% 9% 5% 1
Slide 11: Operational Highlights for the quarter
Operational Highlights for the quarter Capacity Expansion • Full payment completed against acquisitions in Improvement in occupancy across our hospitals New Delhi (expandable capacity 300+ beds) and • Occupancy levels improves to 61% in 9M FY25, ~60% stake in Faridabad (~400 beds) compared to 53% in
Slide 12: Participation by Marquee Investors
Successful QIP of Rs. 6,250 mn in Dec-24 QIP Given immense growth potential in healthcare sector, majority proceeds will be strategically Rs. 6,250 Mn deployed towards bed capacity expansion Net Proceeds proposed to be utilized as below: Participation by Marquee Investors Particulars Planned Outlay
Slide 13: Update on Acquisitions
Update on Acquisitions Expanding footprint in New Delhi & Faridabad – made full payments for both of its recent acquisitions Yet to commence Established Multi-specialty hospital ❖ Strategic collaboration agreement ❖ Successful bidding for MD City Multi-specialty hospital for ~60% stake acquisition,
Slide 14: Other highlights during the period
Other highlights during the period Clinical Achievements Awards & Recognitions Successful Kidney Fastest Growing transplant at Hospital in Medical Greater Noida by Value Travel at transfer through Sanjeevani 2024! Green Corridor Healthcare and Wellness Expo HTI Global Healthcare & Wellness Excellenc
Slide 15: Profit & Loss Summary
Profit & Loss Summary Change Change Change Particulars (Rs Mn) Q3FY25 Q3FY24 Q2FY25 9MFY25 9MFY24 YoY QoQ YoY Revenue from Operations 2,192 1,668 31% 2,178 1% 6,487 4,926 32% Medical Consumables & Pharmacy 421 315 33% 432 (3%) 1,320 956 38% Employee Expenses 426 299 42% 415 3% 1,187 852 39% Other Ex
Slide 16: At a Glance
At a Glance
Slide 17: Leading Super specialty hospital in North India
Leading Super specialty hospital in North India One-stop destination for patient needs providing all levels of 7 11 87% healthcare services from primary to tertiary Hospitals* Center of Excellence Beds in Metros* 2024 2019 Noida Extension 2,300+ Rs. 30,614 61% 450 beds Bed Capacity* ARPOB (9MFY25) O
Slide 18: Our Journey
Our Journey Growing presence across regions and services Established our first Expansion of our first Acquisition of 4th hospital - • Acquired 5th hospital – 200 hospital in Greater hospital, Greater Noida Jhansi Orchha hospital beds in Gr. Faridabad; 6th & Noida hospital, to 400 beds adding 305 bed
Slide 19: Our Hospitals
Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure Greater Noida Jhansi - Greater Diversified revenue mix Hospitals Noida Noida Extension Orchha Faridabad across hospitals Year of Operation 2010 2013 2019 2022 2024 (9MFY25) Beds Capacity 400 250 450 305 200 Ce
Slide 20: Our Mature Hospitals
Our Mature Hospitals 65% Occupancy Greater Noida Provides a wide spectrum of super specialty services in the field of 2010 Incorporated Rs.34,584 ARPOB cardiology, cardiovascular and thoracic surgery, neurology, 400 Beds; 112 ICU Beds neurosurgery, urology, nephrology, oncology, gastroenterology etc
Slide 21: Our New hospitals
Our New hospitals 50% Jhansi – Occupancy Hospital in Jhansi-Orchha-Gwalior region, has Orchha infrastructure to operate all the major super specialties Rs.13,038 ARPOB 2022 Acquisition Acquired in FY22 305 Beds; 76 ICU Beds 3.99 days ALOS 31% Acquired in 2024, a newly built hospital with latest Grea
Slide 22: Healthcare Delivery Market in India is at Nascent stage
Healthcare Delivery Market in India is at Nascent stage Indian hospital market to grow at a CAGR of 10-12% to reach INR 10tn by FY28 Globally India has one of the lowest bed density/10,000 population 70 (INR tn) 50 9.4-9.8 27 6.3 2.6 26 3.9 1.8 25 1.3 7.2 4.5 24 2.6 20 FY19 FY24E FY28P 15 IPD OPD 9
Slide 23: North India - Underserved market with huge growth potential
North India - Underserved market with huge growth potential North India hospital market is expected to grow at a CAGR of 12-14%... …Growing at a faster rate than the overall industry (INR tn) 9-11% 10-12% (INR tn) 3.9 6.3 9.4-9.8 3.1-3.2 10-12% 11-13% 22.5-23.5% 22-24% 22-25% 9-11% 10-12% 1.9-2.0 11
Slide 24: Proximity to international airports to fuel medical tourism
Proximity to international airports to fuel medical tourism India’s medical tourism industry has been growing ~45% of the international patients travel to Delhi-NCR 40% Indira Gandhi Int. Airport Noida Extension (~42 km from IGI; 7.0 Model Town, Delhi 58 km from Jewar) 6.4 (~24 km from IGI) Noida 5.
Slide 25: Yatharth is well positioned in most of the levers
Yatharth is well positioned in most of the levers Yatharth Apollo Max Fortis NH KIMS Jupiter Strategic Levers to improve competence No of beds Beds in ✓ On track to expand bed Metros % capacity to ~3,000 by FY28 Revenue ✓ Increasing share of super 3Y CAGR specialties & introduction of oncology and r
Slide 26: Core strategies driving growth
Core strategies driving growth Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals 01 Capacity Addition 02 Greenfield and brownfield expansion Leverage Technology 03 Advanced and high-end medical equipment and technology 04 Clinical Expertise Attracting best talent to drive
Slide 27: Optimizing existing infrastructure
Optimizing existing infrastructure Mature hospitals New hospitals Total 66% 63% 61% Occupancy (%) 55% 54% 50% 50% 45% 45% Improve 42% 42% Diversifying customer specialties service 23% 8% NM NM FY21 FY22 FY23 FY24 9MFY25 Our 5-fold approach to optimize 34,124 existing infra 29,646 28,571 30,614 Optim
Slide 28: Capacity addition - greenfield and brownfield expansion
Capacity addition - greenfield and brownfield expansion Capacity addition trend and roadmap ahead Operational Beds New bed addition Planned bed addition Target bed capacity ~3,000 Operationalize 450* by Q1 FY26 ~200-300 Operationalize May-24 by Q1 FY26 ~400 ~300 Apr-22 May-19 *Bed capacity to be exp
Slide 29: Advanced and high-end medical equipment and technology
Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce medical technology and state-of-the-art equipment Complex Kidney, Liver & Bone Robotic Surgeries – Marrow Transplant DaVinci, Mako & Cuvis Rad
Slide 30: Attracting best talent to drive super specialties
Attracting best talent to drive super specialties Strategic initiatives aimed to ease attrition Integrating talent from First mover advantage in well-established allied building out network across workforce Tier II/III cities ❑ Introduced DNB program across 8 specialties in 2 of the hospitals ❑ DNB
Slide 31: Proven record of consistent financial performance (1/2)
Proven record of consistent financial performance (1/2) Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 29.3% 2300 2295 30% 2290 2285 2280 2275 2270 2265 2260 2255 2250 27.6% 2245 2240 2235 2230 2225 2220 29% 2215 2210 27.1% 2205 2200 219 219 5 0 26.8% 218 218 5 0 2175 2170 216 216 5 0 215 215 5 0 28% 214
Slide 32: Proven record of consistent financial performance (2/2)
Proven record of consistent financial performance (2/2) Return on capital employed (%) Return on equity (%) 29% 45% 44% 28% 27% 23% 27% 22% 18% 14% FY21 FY22 FY23 FY24 H1FY25 FY21 FY22 FY23 FY24 H1FY25 Gross Block (Rs mn) 130 Net Working Capital Days 125 Capex per bed 120 115 110 105 4.40 100 95 3.9
Slide 33: Consistent performance across operational parameters
Consistent performance across operational parameters Occupancy (%) IPD/OPD Revenue (in ‘000s) IPD Revenue OPD Revenue 6,705 6,487 5,203 819 4,928 755 4,009 684 603 2,287 546 54% 53% 61% 5,886 5,732 50% 45% 4,519 4,324 42% 227 3,464 2,060 FY21 FY22 FY23 FY24 9MFY24 9MFY25 FY21 FY22 FY23 FY24 9MFY24 9
Slide 34: Awards and Accreditations
Awards and Accreditations 2020 2021 2022 2023 2024 ➢ Awarded 1st in ➢ Covid Thank You award ➢ 5-star grading by ➢ Awarded UP Ratan ➢ Awarded Best Brand for Swachhta Ranking (for by Niva Bupa Infomerics Analysts & Samman by Dainik Excellence in Healthcare quarter ended Sep 2019) ➢ Accreditation from
Slide 35: Experienced board and leadership team
Experienced board and leadership team Promila Bhardwaj Dr. Ajay Kumar Tyagi Independent Director Chairman & Whole-time Director 35+ yrs of experience 17+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social Bachelor of medicine, surgery, and diploma in orthopaedics s
Slide 36: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Neeraj Vinayak, Head – Strategy and Investor Relations investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital and Trauma Care Services — Q3 FY2025 Earnings Presentation on 6ix